Arthur M Krieg's Net Worth
-$524 Thousand
Who is Arthur M Krieg?
Arthur M Krieg does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Coley Pharmaceutical Group, Inc., Sarepta Therapeutics, Inc., and Checkmate Pharmaceuticals, Inc..
SEC CIK
Arthur M Krieg's CIK is 0001335659
Past Insider Trading and Trends
2021 was Arthur M Krieg's most active year for acquiring shares with 9 total transactions. Arthur M Krieg's most active month to acquire stocks was the month of February. 2008 was Arthur M Krieg's most active year for disposing of shares, totalling 5 transactions. Arthur M Krieg's most active month to dispose stocks was the month of December. 2021 saw Arthur M Krieg paying a total of $805,692.94 for 84,744 shares, this is the most they've acquired in one year. In 2006 Arthur M Krieg cashed out on 56,211 shares for a total of $418,023.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Coley Pharmaceutical Group, Inc. No price found
SVP, R & D, Chief Scien. Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -561.32K |
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
| -3.72% | -21.07K |
$1.89 | -$39,822.30 | 545.6K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -3.15% | -18.42K |
$2.24 | -$40,593.28 | 566.67K |
Oct 12 - Dec 7
| |||
Form 4
| -2.21% | -13.21K |
$1.89 | -$24,966.90 | 585.09K |
Oct 13
| |||
Form 4
| -3.95% | -24.58K |
$14.34 | -$352,462.86 | 598.3K |
May 8
| |||
Form 4
| +3.49% | 21K |
$1.15 | $24,150.00 | 622.88K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +1.50% | 8.87K |
—
|
—
| 601.88K |
Aug 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92
SVP, Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Checkmate Pharmaceuticals, Inc. No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.89% | 7.22K |
$6.04 | $43,632.96 | 815.73K |
Jun 18
| |||
Form 4
| +0.44% | 3.58K |
$6.18 | $22,112.04 | 808.51K |
Jun 16
| |||
Form 4
| -100.00% | -205.37K |
—
|
—
|
0
|
May 28
| |||
Form 4
| +3.21% | 25K |
$6.97 | $174,256.97 | 804.93K |
May 18
| |||
Form 4
| +4.45% | 33.22K |
$11.16 | $370,672.72 | 779.93K |
Scheduled
|
Mar 29
| ||
Form 4
| +1.84% | 13.52K |
$12.30 | $166,275.20 | 746.71K |
Scheduled
|
Mar 25 - Mar 26
| ||
Form 4
| +0.23% | 1.7K |
$13.05 | $22,198.05 | 733.19K |
Jan 27
| |||
Form 4
| +0.07% | 500 |
$13.09 | $6,545.00 | 731.49K |
Jan 19
| |||
Form 4
| +0.06% | 443 |
$14.16 | $6,272.88 | 730.99K |
Dec 29
| |||
Form 4
| +0.70% | 5.1K |
$14.64 | $74,707.92 | 730.55K |
Dec 22
| |||
Form 4
| +0.67% | 4.85K |
$14.62 | $70,857.68 | 725.44K |
Dec 15 - Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||